Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history

Neurogenetics

Volumn 8, Issue 4, 2007, Pages 263-270

  Rosen, Ami R ^a   Steenland, N Kyle ^b   Hanfelt, John ^b   Factor, Stewart A ^a   Lah, James J ^a   Levey, Allan I ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Familial dementia; Family tree; Neurodegenerative diseases; Odds ratio; Risk assessment

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STRUCTURED INTERVIEW;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MODELS, GENETIC; ODDS RATIO; PARKINSON DISEASE; RISK FACTORS;

EID: 35448992543     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-007-0100-6     Document Type: Article

References (39)

1. Bonifati V, Rizzu P, van Baren MJ et al (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256-259
2. Gasser T, Muller-Myhsok B, Wszolek ZK et al (1998) A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 18:262-265
3. Goate A, Chartier-Harlin MC, Mullan M et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706
4. Kitada T, Asakawa S, Hattori N et al (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605-608
5. Levy-Lahad E, Wasco W, Poorkaj P et al (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977
6. Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047
7. Sherrington R, Rogaev EI, Liang Y et al (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760
8. Strittmatter WJ, Saunders AM, Schmechel D et al (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977-1981
9. Valente EM, Bentivoglio AR, Dixon PH et al (2001) Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet 68:895-900
10. Aarsland D, Andersen K, Larsen JP et al (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60:387-392
11. Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486
12. Boller F, Mizutani T, Roessmann U et al (1980) Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol 7:329-335
13. Hakim AM, Mathieson G (1979) Dementia in Parkinson disease: a neuropathologic study. Neurology 29:1209-1214
14. Hughes AJ, Daniel SE, Blankson S et al (1993) A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 50:140-148
15. Samuel W, Galasko D, Masliah E et al (1996) Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 55:44-52
16. Lippa CF, Smith TW, Nee L et al (1995) Familial Alzheimer's disease and cortical Lewy bodies: is there a genetic susceptibility factor. Dementia 6:191-194
17. Aarsland D, Perry R, Brown A et al (2005) Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann Neurol 58:773-776
18. Baba M, Nakajo S, Tu PH et al (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879-884
19. Fratiglioni L, Ahlbom A, Viitanen M et al (1993) Risk factors for late-onset Alzheimer's disease: a population-based, case-control study. Ann Neurol 33:258-266
20. Huff FJ, Auerbach J, Chakravarti A et al (1988) Risk of dementia in relatives of patients with Alzheimer's disease. Neurology 38:786-790
21. Silverman JM, Raiford K, Edland S et al (1994) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part VI. Family history assessment: a multicenter study of first-degree relatives of Alzheimer's disease probands and nondemented spouse controls. Neurology 44:1253-1259
22. Hofman A, Schulte W, Tanja TA et al (1989) History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease. Neurology 39:1589-1592
23. van Duijn CM, Clayton D, Chandra V et al (1991) Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 20(Suppl 2):S13-S20
24. Van Duijn CM, Clayton DG, Chandra V et al (1994) Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies. EURODEM Risk Factors Research Group. Genet Epidemiol 11:539-551
25. McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944
26. Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson's disease. Ann Neurol 32(Suppl):S125-S127
27. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752
28. Farrer LA, O'Sullivan DM, Cupples LA et al (1989) Assessment of genetic risk for Alzheimer's disease among first-degree relatives. Ann Neurol 25:485-493
29. Sellbach AN, Boyle RS, Silburn PA et al (2006) Parkinson's disease and family history. Parkinsonism Relat Disord 12:399-409
30. Devi G, Ottman R, Tang MX et al (2000) Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan. Arch Neurol 57:72-77
31. Marder K, Levy G, Louis ED et al (2003) Familial aggregation of early- and late-onset Parkinson's disease. Ann Neurol 54:507-513
32. Payami H, Zareparsi S, James D et al (2002) Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease. Arch Neurol 59:848-850
33. Sveinbjornsdottir S, Hicks AA, Jonsson T et al (2000) Familial aggregation of Parkinson's disease in Iceland. N Engl J Med 343:1765-1770
34. Mickel SF, Broste SK, Hiner BC (1997) Lack of overlap in genetic risks for Alzheimer's disease and Parkinson's disease. Neurology 48:942-949
35. Levy G, Louis ED, Mejia-Santana H et al (2004) Lack of familial aggregation of Parkinson disease and Alzheimer disease. Arch Neurol 61:1033-1039
36. Elbaz A, McDonnell SK, Maraganore DM et al (2003) Validity of family history data on PD: evidence for a family information bias. Neurology 61:11-17
37. Li G, Aryan M, Silverman JM et al (1997) The validity of the family history method for identifying Alzheimer disease. Arch Neurol 54:634-640
38. Healy DG, Abou-Sleiman PM, Lees AJ et al (2004) Tau gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry 75:962-965
39. Myers AJ, Kaleem M, Marlowe L et al (2005) The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum Mol Genet 14:2399-2404